Financhill
Sell
25

QRHC Quote, Financials, Valuation and Earnings

Last price:
$6.01
Seasonality move :
5.14%
Day range:
$5.84 - $6.14
52-week range:
$5.84 - $10.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.43x
P/B ratio:
1.97x
Volume:
160.6K
Avg. volume:
56K
1-year change:
-14.65%
Market cap:
$123.5M
Revenue:
$288.4M
EPS (TTM):
-$0.37
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $99M $98.7M $155.7M $284M $288.4M
Revenue Growth (YoY) -4.65% -0.32% 57.83% 82.41% 1.53%
 
Cost of Revenues $80.3M $79.6M $127M $235.2M $238.3M
Gross Profit $18.7M $19.1M $28.7M $48.9M $50.1M
Gross Profit Margin 18.92% 19.31% 18.44% 17.2% 17.36%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $16.8M $17.1M $21.7M $37.8M $37.7M
Other Inc / (Exp) -- $1.2M -- -- --
Operating Expenses $18.1M $18.3M $24.2M $47.5M $47.2M
Operating Income $595.5K $750.3K $4.5M $1.4M $2.8M
 
Net Interest Expenses $431.6K $701.9K $2.5M $7.3M $9.7M
EBT. Incl. Unusual Items $163.8K $1.3M $2M -$5.9M -$6.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $219.1K $254K $321.2K $172.6K $386.9K
Net Income to Company -$55.2K $1M $1.7M -$6M -$7.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$55.2K $1M $1.7M -$6M -$7.3M
 
Basic EPS (Cont. Ops) -$0.00 $0.05 $0.09 -$0.31 -$0.36
Diluted EPS (Cont. Ops) -$0.00 $0.05 $0.08 -$0.31 -$0.36
Weighted Average Basic Share $15.3M $16.7M $18.9M $19.5M $20.1M
Weighted Average Diluted Share $15.3M $16.8M $20.7M $19.5M $20.1M
 
EBITDA $2M $3.3M $7.3M $11.4M $12.8M
EBIT $595.5K $2M $4.5M $1.4M $2.8M
 
Revenue (Reported) $99M $98.7M $155.7M $284M $288.4M
Operating Income (Reported) $595.5K $750.3K $4.5M $1.4M $2.8M
Operating Income (Adjusted) $595.5K $2M $4.5M $1.4M $2.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $23.7M $37.4M $73.4M $70.4M $72.8M
Revenue Growth (YoY) -0.94% 57.66% 96.32% -4% 3.32%
 
Cost of Revenues $19.1M $30.5M $61.2M $58M $61.1M
Gross Profit $4.6M $6.9M $12.2M $12.4M $11.7M
Gross Profit Margin 19.23% 18.34% 16.61% 17.65% 16.08%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.3M $5.3M $9.3M $9.6M $10.3M
Other Inc / (Exp) -$18K -- -- -- --
Operating Expenses $4.4M $5.8M $11.8M $12M $12.6M
Operating Income $116.1K $1M $377.3K $468.5K -$940.3K
 
Net Interest Expenses $72.6K $542.8K $1.9M $2.4M $2.7M
EBT. Incl. Unusual Items $25.5K $493.8K -$1.5M -$1.9M -$3.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $92.1K $108K $151.6K $111.1K -$278.3K
Net Income to Company -$66.6K $385.8K -$1.7M -$2.1M -$3.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$66.6K $385.8K -$1.7M -$2.1M -$3.4M
 
Basic EPS (Cont. Ops) -$0.02 $0.02 -$0.09 -$0.10 -$0.16
Diluted EPS (Cont. Ops) -$0.02 $0.02 -$0.09 -$0.10 -$0.16
Weighted Average Basic Share $17.3M $19M $19.4M $20.1M $20.7M
Weighted Average Diluted Share $17.3M $21.3M $19.4M $20.1M $20.7M
 
EBITDA $273.8K $1.6M $2.9M $2.9M $1.7M
EBIT $98K $1M $377.3K $468.5K -$940.3K
 
Revenue (Reported) $23.7M $37.4M $73.4M $70.4M $72.8M
Operating Income (Reported) $116.1K $1M $377.3K $468.5K -$940.3K
Operating Income (Adjusted) $98K $1M $377.3K $468.5K -$940.3K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $94M $137M $268.2M $281.3M $287.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $75.8M $111.3M $221.5M $232M $237.1M
Gross Profit $18.1M $25.7M $46.7M $49.3M $50.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $16.8M $19.1M $35.1M $38.1M $38.9M
Other Inc / (Exp) $1.2M -- -- -- --
Operating Expenses $18M $20.8M $43.5M $47.6M $48.3M
Operating Income $155.3K $4.9M $3.2M $1.7M $2.4M
 
Net Interest Expenses $331.6K $2.1M $5.9M $9.6M $10.1M
EBT. Incl. Unusual Items $1.1M $2.8M -$2.7M -$7.9M -$7.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $118.6K $452.7K $537.7K $344K $201.7K
Net Income to Company $945.2K $2.4M -$3.3M -$8.3M -$7.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $945.2K $2.4M -$3.3M -$8.3M -$7.9M
 
Basic EPS (Cont. Ops) $0.04 $0.13 -$0.17 -$0.41 -$0.37
Diluted EPS (Cont. Ops) $0.04 $0.12 -$0.18 -$0.41 -$0.37
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $2.6M $6.9M $11.9M $11.6M $12.6M
EBIT $1.4M $4.9M $3.2M $1.7M $2.4M
 
Revenue (Reported) $94M $137M $268.2M $281.3M $287.9M
Operating Income (Reported) $155.3K $4.9M $3.2M $1.7M $2.4M
Operating Income (Adjusted) $1.4M $4.9M $3.2M $1.7M $2.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $71M $109.3M $221.8M $219M $218.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $57.5M $89.2M $183.7M $180.5M $179.3M
Gross Profit $13.5M $20.1M $38.1M $38.6M $39.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $12.7M $14.6M $28M $28.2M $29.5M
Other Inc / (Exp) $1.2M -- -- -- --
Operating Expenses $13.5M $16M $35.3M $35.5M $36.6M
Operating Income -$21.4K $4.1M $2.8M $3.1M $2.7M
 
Net Interest Expenses $244.1K $1.7M $5.1M $7.4M $7.8M
EBT. Incl. Unusual Items $974.6K $2.5M -$2.2M -$4.3M -$5.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $63.8K $262.4K $479K $650.4K $465.1K
Net Income to Company $910.7K $2.2M -$2.7M -$5M -$5.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $910.7K $2.2M -$2.7M -$5M -$5.6M
 
Basic EPS (Cont. Ops) $0.04 $0.12 -$0.14 -$0.24 -$0.26
Diluted EPS (Cont. Ops) $0.04 $0.11 -$0.15 -$0.24 -$0.26
Weighted Average Basic Share $48.2M $56.3M $57.9M $60M $61.6M
Weighted Average Diluted Share $48.2M $61.2M $60M $60M $61.6M
 
EBITDA $2.1M $5.7M $10.4M $10.6M $10.4M
EBIT $1.2M $4.1M $2.8M $3.1M $2.7M
 
Revenue (Reported) $71M $109.3M $221.8M $219M $218.6M
Operating Income (Reported) -$21.4K $4.1M $2.8M $3.1M $2.7M
Operating Income (Adjusted) $1.2M $4.1M $2.8M $3.1M $2.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $3.4M $7.5M $8.4M $9.6M $324K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $13.9M $17.4M $39.9M $45.9M $58.1M
Inventory -- -- -- -- --
Prepaid Expenses $1.1M $1.1M -- -- --
Other Current Assets -- -- $2M $2.3M $2.1M
Total Current Assets $18.4M $26M $50.3M $57.8M $60.6M
 
Property Plant And Equipment $2.1M $3.1M $4.5M $5M $4M
Long-Term Investments -- -- -- -- --
Goodwill $58.2M $66.3M $80.6M $84.3M $85.8M
Other Intangibles $1.6M $6.5M $39.1M $33.6M $26.1M
Other Long-Term Assets $306.6K $293.3K $1.1M $901.7K $634.5K
Total Assets $80.7M $102.2M $175.7M $181.5M $177.1M
 
Accounts Payable $10.4M $12.5M $26.4M $28.7M $38.6M
Accrued Expenses $151.3K $226.3K $230.6K $828.7K $238.1K
Current Portion Of Long-Term Debt -- $624.4K $1.3M $1.2M $1.2M
Current Portion Of Capital Lease Obligations $627.9K $668K $868.8K $489.9K $493.9K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $13.3M $17.3M $37.7M $38.1M $44.9M
 
Long-Term Debt $4.5M $14.9M $62.4M $70.6M $64.6M
Capital Leases -- -- -- -- --
Total Liabilities $19M $34.2M $102M $110.4M $110.8M
 
Common Stock $15.4K $18.4K $19.1K $19.7K $20.2K
Other Common Equity Adj -- -- -- -- --
Common Equity $61.6M $68M $73.6M $71.1M $66.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $61.6M $68M $73.6M $71.1M $66.3M
 
Total Liabilities and Equity $80.7M $102.2M $175.7M $181.5M $177.1M
Cash and Short Terms $3.4M $7.5M $8.4M $9.6M $324K
Total Debt $4.5M $15.6M $63.7M $71.7M $65.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $6.4M $9.1M $7.1M $870.2K $1.1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $15.2M $25.9M $52.1M $49.9M $60.1M
Inventory -- -- -- -- --
Prepaid Expenses $1.3M $1.5M $3.1M -- --
Other Current Assets -- -- -- $2.7M $3.3M
Total Current Assets $22.9M $36.5M $62.2M $53.5M $64.6M
 
Property Plant And Equipment $1.8M $2.7M $5M $4.2M $7.1M
Long-Term Investments -- -- -- -- --
Goodwill $58.2M $66.8M $82.5M $84.3M $85.8M
Other Intangibles $914.2K $7.3M $35.6M $27.8M $20M
Other Long-Term Assets $730.4K $635.1K $952.8K $629.2K $632.1K
Total Assets $84.6M $113.9M $186.3M $170.4M $178.2M
 
Accounts Payable $10.6M $18.7M $29.9M $37.1M $35.7M
Accrued Expenses $199.8K $292.2K $961K $629.9K $527.7K
Current Portion Of Long-Term Debt -- $651.8K $1.2M $1.2M $1.2M
Current Portion Of Capital Lease Obligations $639.6K $681.8K $416.7K $493.1K $449.4K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $13M $24.4M $41.5M $44.6M $42.5M
 
Long-Term Debt $4.2M $15.9M $70.3M $56.8M $71.9M
Capital Leases -- -- -- -- --
Total Liabilities $17.9M $41.9M $113.9M $102.8M $115.4M
 
Common Stock $18.4K $18.8K $19.3K $20K $20.5K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $66.7M $72M $72.4M $67.7M $62.8M
 
Total Liabilities and Equity $84.6M $113.9M $186.3M $170.4M $178.2M
Cash and Short Terms $6.4M $9.1M $7.1M $870.2K $1.1M
Total Debt $4.2M $16.5M $71.5M $57.9M $73.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$55.2K $1M $1.7M -$6M -$7.3M
Depreciation & Amoritzation $1.4M $1.3M $2.8M $10M $9.9M
Stock-Based Compensation $1.1M $1.5M $1.4M $1.3M $1.3M
Change in Accounts Receivable $2.8M -$2.3M -$11.7M -$4.2M -$13.7M
Change in Inventories -- -- -- -- --
Cash From Operations $2.3M $3.1M $2.6M -$2.3M -$1.4M
 
Capital Expenditures $301.3K $506.1K $636.2K $1.7M $1.9M
Cash Acquisitions -- -- -$16.3M -$2.6M --
Cash From Investing -$301.3K -$506.1K -$16.9M -$4.3M -$1.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $99.4M $71.1M $84.7M $84.1M $91.4M
Long-Term Debt Repaid -$100.2M -$71.7M -$70.1M -$77M -$98.5M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$1.1M -$37.5K -$214.6K --
Cash From Financing -$685.7K $1.5M $15.3M $7.8M -$6M
 
Beginning Cash (CF) $2.1M $3.4M $7.5M $8.4M $9.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.3M $4.1M $911.6K $1.1M -$9.2M
Ending Cash (CF) $3.4M $7.5M $8.4M $9.6M $324K
 
Levered Free Cash Flow $2M $2.6M $1.9M -$4M -$3.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$66.6K $385.8K -$1.7M -$2.1M -$3.4M
Depreciation & Amoritzation $175.8K $583K $2.6M $2.4M $2.6M
Stock-Based Compensation $323.8K $325.7K $412.7K $288.6K $571.2K
Change in Accounts Receivable -$1.2M -$2.1M -$1.8M -$5.1M $1.9M
Change in Inventories -- -- -- -- --
Cash From Operations -$688.9K -$1.8M -$521.3K $350K -$474.7K
 
Capital Expenditures $81.7K $297.1K $545.3K $421.7K $349K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$81.7K -$297.1K -$545.3K -$421.7K -$349K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $12.9M $19.2M $23M $23.5M $27.8M
Long-Term Debt Repaid -$12.5M -$18.2M -$19.2M -$25.9M -$26.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$131.3K -- -$93.8K -- -$34.8K
Cash From Financing $3.2M $1.2M $3.9M -$2M $999.5K
 
Beginning Cash (CF) $4M $10M $4.2M $3M $957.6K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.5M -$947.6K $2.9M -$2.1M $175.7K
Ending Cash (CF) $6.4M $9.1M $7.1M $870.2K $1.1M
 
Levered Free Cash Flow -$770.6K -$2.1M -$1.1M -$71.6K -$823.7K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $945.2K $2.4M -$3.3M -$8.3M -$7.9M
Depreciation & Amoritzation $1.2M $1.9M $8.8M $9.9M $10.2M
Stock-Based Compensation $1.4M $1.5M $1.2M $1.2M $1.7M
Change in Accounts Receivable -$1M -$9.4M -$16.3M $3.7M -$11.4M
Change in Inventories -- -- -- -- --
Cash From Operations $2M $5.6M -$5.1M $8.6M -$9.3M
 
Capital Expenditures $395.2K $718K $1.4M $1.7M $5.8M
Cash Acquisitions -- -$2.3M -$17.1M $501.6K --
Cash From Investing -$395.2K -$3M -$18.5M -$1.2M -$5.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $82.3M $60.4M $98.8M $85.2M $111.8M
Long-Term Debt Repaid -$82.5M -$60M -$77.6M -$99.8M -$97.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $2.8M $92K $21.6M -$13.7M $15.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.4M $2.7M -$2M -$6.2M $263K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.6M $4.9M -$6.5M $7M -$15.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $910.7K $2.2M -$2.7M -$5M -$5.6M
Depreciation & Amoritzation $871.9K $1.5M $7.5M $7.5M $7.7M
Stock-Based Compensation $1.1M $1.1M $998.3K $949.3K $1.3M
Change in Accounts Receivable -$1.3M -$8.4M -$13.1M -$5.3M -$2.9M
Change in Inventories -- -- -- -- --
Cash From Operations $844.8K $3.4M -$4.3M $6.7M -$1.3M
 
Capital Expenditures $303.7K $515.7K $1.3M $1.3M $5.2M
Cash Acquisitions -- -$2.3M -$3.1M -- --
Cash From Investing -$303.8K -$2.8M -$4.4M -$1.3M -$5.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $59.2M $48.4M $62.5M $63.7M $84M
Long-Term Debt Repaid -$59.7M -$48M -$55.5M -$78.3M -$77.1M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$131.3K -- -$139.6K -- -$457.8K
Cash From Financing $2.5M $1.1M $7.4M -$14.1M $7.3M
 
Beginning Cash (CF) $10.7M $28.3M $20.6M $22.3M $1.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3M $1.6M -$1.3M -$8.7M $809.3K
Ending Cash (CF) $13.7M $29.9M $19.2M $13.7M $2.7M
 
Levered Free Cash Flow $541K $2.9M -$5.6M $5.4M -$6.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 0.37% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.53% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 6.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock